Hong Jen Chang
Chief Executive Officer at EUSOL BIOTECH CO.,LTD.
Profile
Hong Jen Chang is currently the Chairman & Chief Executive Officer at YFY Biotech Management Co. He is also the Chairman at MiCareo Taiwan Co., Ltd.
and the Chairman & General Manager at Eusol Biotech Co., Ltd.
Additionally, he holds director positions at TaiGen Biotechnology Co., Ltd., TaiGen Biopharmaceuticals Holdings Ltd., NeuroSky, Inc., Taiwan Genome Sciences, Inc., Taiwan Global BioFund, MiCareo, Inc., Medeon Biodesign, Inc., Excelsior Biopharma, Inc., Medeon Biosurgical, Inc., Sunny Pharma Holding Ltd., Medeon International, Inc., Formosa Pharmaceuticals, Inc., Acepodia Biotechnologies, Ltd., Acepodia, Inc., and serves as the President of the Taiwan Pharmaceutical Manufactureres Association.
In the past, Mr. Chang served as the President & Chief Executive Officer of National Health Insurance.
He was also a Non-Executive Director at TBG Diagnostics Ltd.
and held director positions at Mycenax Biotech, Inc., Pharmigene, Inc., Taiwan Liposome Co., Ltd., TaiMed Biologics, Inc., TWi Biotechnology, Inc., Sunny Pharmtech Inc., Somnics, Inc., iXensor Co., Ltd., SyneuRx International (Taiwan) Corp., and AP Biosciences, Inc.Mr. Chang completed his undergraduate degree at National Yang Ming University in 1982.
He then went on to graduate from National Taiwan University in 1984 and Harvard T.H.
Chan School of Public Health in 1987.
Hong Jen Chang active positions
Companies | Position | Start |
---|---|---|
TAIGEN BIOPHARMACEUTICALS HOLDINGS LIMITED | Director/Board Member | 31/03/2013 |
EUSOL BIOTECH CO.,LTD. | Chief Executive Officer | - |
FORMOSA PHARMACEUTICALS, INC. | Director/Board Member | 31/05/2020 |
MEDEON BIODESIGN, INC. | Director/Board Member | 13/01/2014 |
TOT BIOPHARM INTERNATIONAL COMPANY LIMITED | Director/Board Member | 11/03/2019 |
EXCELSIOR BIOPHARMA INC. | Director/Board Member | 11/04/2015 |
ACEPODIA, INC. | Director/Board Member | 16/01/2018 |
YFY Biotech Management Co
YFY Biotech Management Co Investment ManagersFinance YFY Biotech Management Co. Ltd. (YFYBM) is a private equity investment firm located in Taipei, Taiwan. Established in 2003, they are subsidiary of the Yuen Foong Yu Group Co. Ltd., founded in 1926 with their core business initially focused on paper manufacturing. YFYBM is the investment manager of biotechnology private equity fund | Chief Executive Officer | 12/07/2015 |
Sunny Pharma Holding Ltd. | Director/Board Member | - |
░░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Former positions of Hong Jen Chang
Companies | Position | End |
---|---|---|
░░░░░░ ░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░ ░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
░░░ ░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Hong Jen Chang
National Taiwan University | Graduate Degree |
National Yang Ming University | Undergraduate Degree |
Harvard T.H. Chan School of Public Health | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 15 |
---|---|
TAIGEN BIOPHARMACEUTICALS HOLDINGS LIMITED | Health Technology |
MYCENAX BIOTECH INC. | Health Technology |
PHARMIGENE, INC. | Health Technology |
TAIMED BIOLOGICS INC. | Health Technology |
TWI BIOTECHNOLOGY, INC. | Health Technology |
TOT BIOPHARM INTERNATIONAL COMPANY LIMITED | Health Technology |
SUNNY PHARMTECH INC. | Health Services |
SOMNICS, INC. | Electronic Technology |
MEDEON BIODESIGN, INC. | Electronic Technology |
IXENSOR CO., LTD. | Health Technology |
AP BIOSCIENCES INC | Health Technology |
FORMOSA PHARMACEUTICALS, INC. | Health Technology |
EUSOL BIOTECH CO.,LTD. | Health Technology |
ACEPODIA, INC. | Health Technology |
EXCELSIOR BIOPHARMA INC. | Health Technology |
Private companies | 16 |
---|---|
TBG Diagnostics Ltd.
TBG Diagnostics Ltd. Pharmaceuticals: MajorHealth Technology TBG Diagnostics Ltd. engages in the research, development, and manufacture of biopharmaceuticals. It operates through the InVitro Diagnostics segment, which involves in the research of biological drugs and the retail and wholesale of veterinary drugs. The company was founded on September 26, 1989 and is headquartered in Melbourne, Australia. | Health Technology |
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Health Technology |
YFY Biotech Management Co
YFY Biotech Management Co Investment ManagersFinance YFY Biotech Management Co. Ltd. (YFYBM) is a private equity investment firm located in Taipei, Taiwan. Established in 2003, they are subsidiary of the Yuen Foong Yu Group Co. Ltd., founded in 1926 with their core business initially focused on paper manufacturing. YFYBM is the investment manager of biotechnology private equity fund | Finance |
Taiwan Liposome Co., Ltd.
Taiwan Liposome Co., Ltd. Pharmaceuticals: MajorHealth Technology Taiwan Liposome Co., Ltd. engages in the research and development of lipid-based formulation drugs. Its products are used for pain management, eye disease treatment, and cancer treatment. The company was founded by Kee Lung Hong on November 10, 1997 and is headquartered in Taipei, Taiwan. | Health Technology |
NeuroSky, Inc.
NeuroSky, Inc. SemiconductorsElectronic Technology NeuroSky, Inc. develops biosensor technology services. Its biosensors, biometric algorithms, reference designs, and big data analytics enable leading-edge innovation in mhealth products and services for measuring body and mind performance. The company was founded by Hyung Koo Lee and Jong Jin Lim in 2004 and is headquartered in San Jose, CA. | Electronic Technology |
Taiwan Genome Sciences, Inc. | |
Taiwan Global BioFund
Taiwan Global BioFund Investment ManagersFinance Taiwan Global BioFund invests exclusively in life science companies located in Taiwan and US. The fund targets companies operating in the fields of biotechnology, pharmaceuticals, diagnostics, medical devices, medical services, and medical informatics. It provides financing for seed, early and later stage capital requirements. | Finance |
National Health Insurance /Taiwan/ | |
MiCareo Taiwan Co., Ltd.
MiCareo Taiwan Co., Ltd. BiotechnologyHealth Technology MiCareo Taiwan Co., Ltd. provides tools for the analysis of rare cells. | Health Technology |
MiCareo, Inc.
MiCareo, Inc. BiotechnologyHealth Technology MiCareo, Inc. provides tools for the analysis of rare cells. It circulates tumor cell platform does rare cell isolation and analysis for cancer prognosis, treatment development, and efficacy evaluation. The firm’s product MiSelect starts with whole blood labeled with any fluorescent cell surface antibody or cocktail of multiple antibodies. The company was founded by Perry Schiro and Daniel T. Chiu in 2011 and is headquartered in Taipei, Taiwan. | Health Technology |
SyneuRx International (Taiwan) Corp.
SyneuRx International (Taiwan) Corp. BiotechnologyHealth Technology SyneuRx International (Taiwan) Corp. engages in the manufacture and sale of medicines. It offers different kinds of medicines, which are useful for brain disorders like schizophrenia have largely failed to materialize and mental illnesses like depression, obsessive compulsive disorder, attention deficit hyperactivity disorder, autism and dementia. The company was founded by Kuo Chuan Tsai on April 2, 2013 and is headquartered in New Taipei, Taiwan. | Health Technology |
Medeon Biosurgical, Inc. | |
Sunny Pharma Holding Ltd. | |
Medeon International, Inc. | |
Acepodia Biotechnologies, Ltd.
Acepodia Biotechnologies, Ltd. BiotechnologyHealth Technology Acepodia Biotechnologies, Ltd. engages in the development of cell therapies to treat patients with cancers. Its business information includes biotechnology service industry, intellectual property rights, and wholesale and retail trade of chemical raw materials. The company was founded by Patrick Yang, and by Sonny Hsiao on June 19, 2017 and is headquartered in Taipei, Taiwan. | Health Technology |
Taiwan Pharmaceutical Manufactureres Association |
- Stock Market
- Insiders
- Hong Jen Chang